Diabetes

Janssen-Cilag Ltd are the UK marketing authorisation holder.

Great Britain – Invokana® tablets (canagliflozin hemihydrate)

SPC PIL

Northern Ireland – Invokana® tablets (canagliflozin hemihydrate)

SPC PIL

Great Britain – Vokanamet® (canagliflozin/metformin)

SPC PIL

Northern Ireland – Vokanamet® (canagliflozin/metformin)

SPC PIL

We own and maintain the following websites:

www.invokanapatient.co.uk

Information for patients receiving Invokana

Date of preparation: March 2021 UK-DIAB-2100040

Stay connected

Date of preparation: March 2021 UK-DIAB-2100040